ACVR2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.69729999949442E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.421500E-03 |
Normal-vs-Stage2 |
1.75225999999862E-05 |
Normal-vs-Stage3 |
3.58935103861313E-12 |
Normal-vs-Stage4 |
2.00395255944841E-12 |
Stage1-vs-Stage2 |
3.030000E-02 |
Stage1-vs-Stage3 |
1.25429999997539E-06 |
Stage1-vs-Stage4 |
1.19169999979185E-07 |
Stage2-vs-Stage3 |
1.451610E-01 |
Stage2-vs-Stage4 |
6.041500E-02 |
Stage3-vs-Stage4 |
4.941400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.57610000500941E-08 |
Normal-vs-AfricanAmerican |
1.424670E-03 |
Normal-vs-Asian |
1.506430E-01 |
Caucasian-vs-AfricanAmerican |
8.613600E-01 |
Caucasian-vs-Asian |
6.454200E-01 |
AfricanAmerican-vs-Asian |
7.209800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.53379999496318E-08 |
Normal-vs-Female |
9.74910000000051E-05 |
Male-vs-Female |
2.682800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.582900E-03 |
Normal-vs-Age(41-60Yrs) |
9.79300000000238E-05 |
Normal-vs-Age(61-80Yrs) |
1.81579999924963E-08 |
Normal-vs-Age(81-100Yrs) |
3.15520000016001E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.475800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.625000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.576200E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.553700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.021200E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.125790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.950800E-01 |
Normal-vs-Grade 2 |
1.897900E-02 |
Normal-vs-Grade 3 |
1.61000102139042E-11 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
2.786800E-01 |
Grade 1-vs-Grade 3 |
2.367700E-02 |
Grade 1-vs-Grade 4 |
2.055200E-03 |
Grade 2-vs-Grade 3 |
1.68495999999241E-05 |
Grade 2-vs-Grade 4 |
9.99200722162641E-16 |
Grade 3-vs-Grade 4 |
1.64659999968286E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.061750E-02 |
Normal-vs-ccB subtype |
7.32240001966034E-09 |
ccA subtype-vs-ccB subtype |
8.607600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.70220000048371E-07 |
Normal-vs-N1 |
9.81629999952105E-07 |
N0-vs-N1 |
7.676400E-03 |
|
|